• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新辅助化疗后转移性腋窝淋巴结的碘-125 粒子定位面临的挑战

Challenges to I-125 Seed Localization of Metastatic Axillary Lymph Nodes Following Neoadjuvant Chemotherapy.

作者信息

Hyde Brenda, Geske Jennifer, Lee Christine

机构信息

Mayo Clinic, Department of Radiology, Division of Breast Imaging and Intervention, Rochester, MN.

Mayo Clinic, Department of Biomedical Statistics and Informatics, Rochester, MN.

出版信息

J Breast Imaging. 2019 Sep 4;1(3):223-229. doi: 10.1093/jbi/wbz032.

DOI:10.1093/jbi/wbz032
PMID:38424762
Abstract

OBJECTIVE

The objective of this retrospective study is to characterize challenges with ultrasound (US)-guided localization of clipped metastatic axillary lymph nodes after neoadjuvant chemotherapy.

METHODS

After institutional review board approval, our radiology database was searched for all radioactive seed localizations (RSLs), which use a low-dose radioactive isotope, Iodine-125, performed for clipped axillary lymph nodes between January 1, 2016, and December 31, 2018. The details of each procedure were reviewed. RSL was defined to be successful if US-guidance was used, and postlocalization imaging showed the seed was no more than 1 cm away from the target. Cause and subsequent management of unsuccessful localizations were documented.

RESULTS

During the study period, 139 clipped axillary lymph nodes (in 138 women and 1 man) were scheduled for preoperative RSL. The overall success rate of RSL was 106/139 (76%). The number of unsuccessful localizations was 10/37 (27%) in 2016, 7/39 (18%) in 2017, and 16/63 (25%) in 2018, with a total unsuccessful case frequency of 33/139 (24%) over the entire study period. The mean time interval between marker placement and localization was 6.0 months (range 0.4-18.1 months). The coil biopsy marker was the most frequently used marker.

CONCLUSIONS

Preoperative US-guided I-125 seed localization of clipped metastatic axillary lymph nodes is suboptimal or unsuccessful 24% of the time. Other options for non-US imaging-guided localizations, such as tomosynthesis, are available for consideration when US detection is unsuccessful.

摘要

目的

本回顾性研究的目的是描述新辅助化疗后超声(US)引导下定位夹闭的转移性腋窝淋巴结所面临的挑战。

方法

经机构审查委员会批准后,在我们的放射学数据库中搜索2016年1月1日至2018年12月31日期间对夹闭的腋窝淋巴结进行的所有放射性种子定位(RSL),该定位使用低剂量放射性同位素碘-125。审查了每个操作的详细信息。如果使用了超声引导且定位后成像显示种子与目标的距离不超过1厘米,则RSL被定义为成功。记录了定位失败的原因及后续处理。

结果

在研究期间,计划对139个夹闭的腋窝淋巴结(138名女性和1名男性)进行术前RSL。RSL的总体成功率为106/139(76%)。2016年定位失败的数量为10/37(27%),2017年为7/39(18%),2018年为16/63(25%),整个研究期间定位失败的总病例频率为33/139(24%)。标记放置与定位之间的平均时间间隔为6.0个月(范围0.4 - 18.1个月)。线圈活检标记是最常用的标记。

结论

术前超声引导下对夹闭的转移性腋窝淋巴结进行碘-125种子定位有24%的时间效果欠佳或不成功。当超声检测不成功时,可考虑其他非超声成像引导定位的选项,如断层合成成像。

相似文献

1
Challenges to I-125 Seed Localization of Metastatic Axillary Lymph Nodes Following Neoadjuvant Chemotherapy.新辅助化疗后转移性腋窝淋巴结的碘-125 粒子定位面临的挑战
J Breast Imaging. 2019 Sep 4;1(3):223-229. doi: 10.1093/jbi/wbz032.
2
Feasibility of targeted axillary dissection for de-escalation of surgical treatment after neoadjuvant chemotherapy in breast cancer.新辅助化疗后降阶梯手术治疗乳腺癌时行靶向腋窝清扫术的可行性。
Surg Oncol. 2022 Sep;44:101823. doi: 10.1016/j.suronc.2022.101823. Epub 2022 Aug 2.
3
Would Removal of All Ultrasound Abnormal Metastatic Lymph Nodes Without Sentinel Lymph Node Biopsy Be Accurate in Patients with Breast Cancer with Neoadjuvant Chemotherapy?新辅助化疗后乳腺癌患者行前哨淋巴结活检而不切除所有超声异常转移淋巴结是否准确?
Oncologist. 2020 Nov;25(11):e1621-e1627. doi: 10.1634/theoncologist.2020-0494. Epub 2020 Jul 7.
4
Feasibility of Ultrasound-Guided Localization for Clipped Metastatic Axillary Lymph Nodes After Neoadjuvant Chemotherapy in Breast Cancer Patients: A Pilot Study.超声引导下定位乳腺癌患者新辅助化疗后腋窝转移淋巴结夹闭术的可行性:一项初步研究
J Breast Cancer. 2023 Feb;26(1):77-85. doi: 10.4048/jbc.2023.26.e6.
5
Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes.乳腺癌新辅助化疗后的腋窝分期:一项将前哨淋巴结活检与治疗前阳性腋窝淋巴结放射性粒子定位相结合的初步研究。
Ann Surg Oncol. 2016 May;23(5):1549-53. doi: 10.1245/s10434-015-5052-8. Epub 2016 Jan 4.
6
Improving the Accuracy of Axillary Lymph Node Surgery in Breast Cancer with Ultrasound-Guided Wire Localization of Biopsy Proven Metastatic Lymph Nodes.通过超声引导下活检证实的转移性淋巴结金属丝定位提高乳腺癌腋窝淋巴结手术的准确性
Ann Surg Oncol. 2015 Dec;22(13):4241-6. doi: 10.1245/s10434-015-4527-y. Epub 2015 Mar 27.
7
Intermediary clip placement to assist accurate axillary lymph node localization.中间夹的放置以协助准确的腋窝淋巴结定位。
Clin Imaging. 2021 May;73:96-100. doi: 10.1016/j.clinimag.2020.11.042. Epub 2020 Dec 3.
8
Feasibility of Preoperative Axillary Lymph Node Marking with a Clip in Breast Cancer Patients Before Neoadjuvant Chemotherapy: A Preliminary Study.新辅助化疗前乳腺癌患者术前用夹子标记腋窝淋巴结的可行性:一项初步研究
World J Surg. 2018 Feb;42(2):582-589. doi: 10.1007/s00268-017-4171-8.
9
Node-Positive Patients Treated with Neoadjuvant Chemotherapy Can Be Spared Axillary Lymph Node Dissection with Wireless Non-Radioactive Localizers.新辅助化疗后前哨淋巴结阳性的患者可以使用无线非放射性定位器避免腋窝淋巴结清扫。
Ann Surg Oncol. 2020 Nov;27(12):4819-4827. doi: 10.1245/s10434-020-08902-y. Epub 2020 Aug 1.
10
Localizing the Clipped Node in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Early Learning Experience and Challenges.局部区域淋巴结阳性乳腺癌患者新辅助化疗后前哨淋巴结定位:早期学习经验与挑战。
Ann Surg Oncol. 2017 Oct;24(10):3011-3016. doi: 10.1245/s10434-017-6023-z. Epub 2017 Aug 1.

引用本文的文献

1
Underlying factors that affect ultrasound conspicuity of breast biopsy markers: an exploratory study.影响乳腺活检标记物超声显影的潜在因素:一项探索性研究。
Transl Breast Cancer Res. 2025 Jan 21;6:2. doi: 10.21037/tbcr-24-48. eCollection 2025.
2
A Radiological Clip Design Using Ultrasound Identification to Improve Localization.一种使用超声识别的放射学夹设计,以提高定位准确性。
IEEE Trans Biomed Eng. 2024 Sep;71(9):2699-2707. doi: 10.1109/TBME.2024.3388203. Epub 2024 Aug 21.
3
Using 3-D-Printed Structures to Evaluate the Potential Causes of the Color Doppler Twinkling Signature.
使用3D打印结构评估彩色多普勒闪烁伪像的潜在原因。
Ultrasound Med Biol. 2024 May;50(5):671-679. doi: 10.1016/j.ultrasmedbio.2024.01.005. Epub 2024 Feb 7.
4
Using US Twinkling Artifact to Identify Breast Biopsy Markers: Brief Report.应用美国闪烁体标识物识别乳腺活检标志物:简要报告。
Radiol Imaging Cancer. 2023 Jul;5(4):e220168. doi: 10.1148/rycan.220168.
5
Ultrasonographic Detection and Surgical Retrieval of a Nonmetallic Twinkle Marker in Breast Cancer: Pilot Study.超声检测及手术取出乳腺癌中非金属“闪烁”标记物:初步研究。
Radiol Imaging Cancer. 2022 Nov;4(6):e220053. doi: 10.1148/rycan.220053.